Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Comprehensive Genomic Profiling of Renal Cancer Cases

ABSTRACT: Comprehensive Genomic Profiling of Renal Cancer Cases

PROVIDER: PRJNA1250523 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR33132100_1.fastq.gz	Fastqsanger.gz
	SRR33132100_2.fastq.gz	Fastqsanger.gz
	SRR33132101_1.fastq.gz	Fastqsanger.gz
	SRR33132101_2.fastq.gz	Fastqsanger.gz
	SRR33132102_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 242

Similar Datasets

Comprehensive Genomic Profiling of Renal Cancer Cases

Project description:Comprehensive Genomic Profiling (CGP) is a technique that comprehensively examines a wide range of cancer-related genetic alterations—such as mutations, copy number variations, and gene fusions—from a single specimen. In the field of renal cancer (primarily renal cell carcinoma), where treatment options like molecularly targeted therapies and immune checkpoint inhibitors continue to expand, there is growing interest in understanding each patient’s mutational profile to enable more personalized treatment strategies.

2025-05-06 | GSE294575 | GEO

Comprehensive genomic characterization of translocation renal cell carcinoma.

Project description:Comprehensive genomic characterization of translocation renal cell carcinoma.

| PRJNA865001 | ENA

Comprehensive genomic characterization of translocation renal cell carcinoma.

Project description:Comprehensive genomic characterization of translocation renal cell carcinoma.

| PRJNA865000 | ENA

Gene expression of papillary renal neoplasm with reverse polarity (PRNRP) cases + PRCC cases

Project description:Between 80% and 90% of renal carcinomas are either clear cell renal cell carcinoma or papillary RCC although there are at least 20 other distinct forms of RCC recognised by the World Health Organization (WHO). Emerging or provisional entities have been considered as variants of PRCC, including papillary renal neoplasm with reversed polarity (PRNRP). However, the molecular basis of PRNRP is unknown. We used microarray analysis to elucidate the gene profile of 10 PRNRP cases and an additional 7 PRCC cases. Cases were only considered for this study after fulfilment of strict inclusive histological and immunohistochemical criteria. We used Affymetrix Clariom D human arrays to elucidate the expression of these samples.

2024-02-18 | GSE255706 | GEO

Gene expression of papillary renal neoplasm with reverse polarity (PRNRP) cases + PRCC cases

Project description:Gene expression of papillary renal neoplasm with reverse polarity (PRNRP) cases + PRCC cases

| PRJNA1076203 | ENA

Genomic profiling of chromophobe renal cell carcinoma by array-based comparative genomic hybridization

Project description:In this study, we investigated CNAs of 4 tumor samples from 2 patients, including conventioanl chromophobe renal cell carcinoma(ChRCC), ChRCC with neuroendocrine differentiation and no-tumor region by 44k oligonucleotide-based array comparative genomic hybridization (array CGH). 2 cases of ChRCC(NOS) vs ChRCC with neuroendocrine differentiation

2015-01-21 | E-GEOD-52641 | biostudies-arrayexpress

miRNA expression of papillary renal neoplasm with reverse polarity (PRNRP) cases

Project description:Between 80% and 90% of renal carcinomas are either clear cell renal cell carcinoma or papillary RCC although there are at least 20 other distinct forms of RCC recognised by the World Health Organization (WHO). Emerging or provisional entities have been considered as variants of PRCC, including papillary renal neoplasm with reversed polarity (PRNRP). However, the molecular basis of PRNRP, and miRNA expression profile, is unknown. We used microarray analysis to elucidate the non-coding RNA (ncRNA) profiles of 10 PRNRP cases and compared them with other renal neoplasms. Cases were only considered for this study after fulfilment of strict inclusive histological and immunohistochemical criteria. We used Affymetrix miRNA v.4.0 arrays to elucidate the expression of these samples.

2024-02-18 | GSE255707 | GEO

a-CGH of Esophageal Cancer (53 cases)

Project description:Esophageal cancer is one of the most aggressive cancers and the sixth leading cause of cancer death worldwide. Approximately 70% of the global esophageal cancers occur in China and over 90% histopathological forms of this disease are esophageal squamous cell carcinoma (ESCC). Currently, there are limited clinical approaches for early diagnosis and treatment for ESCC, resulting in a 10% 5-year survival rate for the patients. Meanwhile, the full repertoire of genomic events leading to the pathogenesis of ESCC remains unclear. Here we show a comprehensive genomic analysis in 158 ESCC cases, as part of the International Cancer Genome Consortium (ICGC) Research Projects (http://icgc.org/icgc/cgp/72/371/1001734). We conducted whole-genome sequencing in 17 ESCC cases and whole-exome sequencing in 71 cases, of which 53 cases and additional 70 ESCC cases were subjected to array comparative genomic hybridization (a-CGH) analysis.

2014-03-11 | GSE54994 | GEO

a-CGH of Esophageal Cancer (70 cases)

2014-03-11 | GSE54993 | GEO

a-CGH of Esophageal Cancer (70 cases)

2014-03-11 | E-GEOD-54993 | biostudies-arrayexpress